Clinical Trial Update: Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluating whether doxycycline plus rifampicin affects biomarkers in the cerebrospinal fluid of people with Alzheimer's disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Doxycycline (Doxycycline)
• Rifampicin

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED